ProfileGDS5678 / 1430639_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 15% 15% 15% 13% 16% 17% 15% 15% 15% 15% 15% 15% 15% 15% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.3962215
GSM967853U87-EV human glioblastoma xenograft - Control 22.3787415
GSM967854U87-EV human glioblastoma xenograft - Control 32.3795815
GSM967855U87-EV human glioblastoma xenograft - Control 42.287813
GSM967856U87-EV human glioblastoma xenograft - Control 52.3545416
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.4686117
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.3953615
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.3559415
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.3505915
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.3659415
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.362415
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.3436415
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.3683415
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.3660615